Tesamorelin ���景与作用机制 — Complete Guide

By Editorial Desk · published 2025-12-18 · last reviewed 2026-02-06 · Faq

The short version of lipodystrophy fits in a sentence. The long version — which is the one that helps — is below.

Reviewed 2026-02-06. Anything still debated is marked as such rather than presented as settled.

tesamorelin 背景与作用机制

研究背景集中在特定人群的体成分改变，尤其是与脂肪分布异常相关的内脏脂肪堆积。不同地区对它的监管状态与获批适应症并不一致，部分市场仅限特定诊断人群使用。在一般人群中的长期效应、与其他激素的相互作用以及停药后的维持情况仍属开放问题，现有数据不足以给出普遍结论。

tesamorelin 是一种人工合成的四十四肽，序列与内源性生长激素释放激素（GHRH）的 1-44 片段一致，区别在于 N 端加接了一个反式-3-己烯酰基。该修饰抑制二肽基肽酶 IV 的快速切割，从而延长分子在循环中的存留时间。作为肽类分子，它难以经胃肠道吸收，文献中讨论的均是注射途径。分类上通常把它归为 GHRH 类似物，以区别于生长激素本身。

Molecular Background and Receptor Mechanism

Physicochemical behavior is dominated by the peptide backbone. The molecule is hydrophilic and carries a net positive charge near neutral pH, owing to several arginine and lysine residues. In solution it adopts a largely unstructured conformation, and aggregation is a known concern for peptide products of this size. Oxidation of methionine and deamidation of asparagine or glutamine residues are the principal chemical degradation routes. These liabilities shape how the material is formulated, handled, and analyzed, and they explain why lyophilized presentations are common in research settings.

Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, built from 44 amino acids. Its sequence follows the natural human GHRH(1-44) backbone, with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification blocks recognition by dipeptidyl peptidase IV, the enzyme that rapidly truncates the native hormone in circulation. The result is a molecule with a substantially longer plasma residence time than unmodified GHRH, which makes it practical for clinical and laboratory study.

Tesamorelin at a glance

Background and Clinical Profile

After injection, the peptide binds receptors on somatotroph cells in the anterior pituitary. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone into the bloodstream. Because the compound works through the body's own regulatory system, growth hormone pulses retain much of their normal feedback control. Repeated administration also raises insulin-like growth factor 1, a hormone produced mainly in the liver. Investigators treat that rise as a marker that the pituitary axis has been engaged.

Clinical study of tesamorelin has centered on adults with HIV-associated lipodystrophy, a condition in which abdominal fat accumulates while peripheral fat is lost. In controlled trials, treated participants showed reductions in visceral adipose tissue measured by imaging, alongside modest shifts in some lipid values. Effects on subcutaneous fat were smaller and less consistent across studies. Whether these changes translate into fewer cardiovascular events remains an open question, because the trials were not designed or powered to answer it.

Tesamorelin is a synthetic peptide that acts as an analog of growth hormone-releasing hormone, a natural hypothalamic signal. Its sequence corresponds to the forty-four amino acid form of the human hormone, with a small acyl group attached near the amino terminus. That modification slows enzymatic breakdown and extends the time the peptide remains active in circulation. The compound was developed as a pharmacological way to raise endogenous growth hormone output rather than supplying the hormone directly.

Related pages on this site

• Simple playbook
• Scheduled comparison
• Automated briefing
• Modular index
• Clear collection
• Tracked notes
• Smart archive
• Scalable casebook

Identity and Development Background

Tesamorelin is a synthetic peptide of 44 amino acids that reproduces the sequence of human growth hormone-releasing hormone (GHRH) and carries a trans-3-hexenoyl group on its N-terminal tyrosine. That small fatty-acid modification blocks cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GHRH in plasma. The result is a molecule with a longer circulating half-life than the natural hormone while retaining the same receptor target. It is supplied as a lyophilized powder for reconstitution and belongs to the broader class of GHRH analogs studied for effects on pituitary growth hormone secretion.

Development work on the compound, originally designated TH9507, focused on conditions in which reduced growth hormone signaling is thought to contribute to altered body composition. The United States Food and Drug Administration approved it in 2010 for the treatment of excess visceral abdominal fat in adults with human immunodeficiency virus infection and lipodystrophy. Later research examined other populations, including adults with mild cognitive impairment, where a large trial did not meet its primary endpoints. This mixed record illustrates how a single mechanism can produce clear effects in one setting and inconclusive results in another.

Background and Clinical Development

Tesamorelin is a synthetic analog of growth hormone-releasing hormone, a peptide hormone produced by the hypothalamus. The molecule retains the 44-amino-acid sequence of human GHRH and carries a trans-3-hexenoyl modification at its N-terminus. This modification increases resistance to enzymatic degradation and extends the peptide's functional stability relative to native GHRH. The compound is supplied as a lyophilized powder for reconstitution and subcutaneous administration in clinical settings. Its development code was TH9507, and it belongs to the GHRH analog class. It is not a growth hormone product; instead, it acts upstream to stimulate endogenous growth hormone release.

Clinical interest in tesamorelin arose from the need to address visceral adiposity in people living with HIV. Antiretroviral therapy improved survival but was associated in some patients with central fat accumulation, altered lipid profiles, and metabolic complications. This condition, often called HIV-associated lipodystrophy, involves excess visceral adipose tissue that is difficult to manage through diet and exercise alone. Investigators evaluated tesamorelin because GHRH analogs can stimulate growth hormone secretion and influence fat distribution without direct liposuction or invasive procedures.

A Phase 3 program led to regulatory approval in the United States in 2010 for reduction of excess visceral abdominal fat in adults with HIV and lipodystrophy. Subsequent studies examined effects on liver fat, muscle area, and metabolic markers, with mixed findings for some endpoints. Long-term cardiovascular outcomes and effects on mortality remain uncertain because most trials were relatively short and focused on imaging-based fat measurements. Use in populations without HIV has been studied experimentally but is not part of the approved indication.

Tesamorelin Background and Mechanism

Binding of tesamorelin to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and the release of growth hormone into circulation. Because the peptide acts upstream of the growth hormone axis, its effects are partly mediated by hepatic insulin-like growth factor 1 (IGF-1) production. The pulsatile character of endogenous growth hormone secretion is preserved rather than replaced. Whether amplified signaling produces effects beyond those of native GHRH remains an area of ongoing investigation.

A documented effect of tesamorelin is a reduction in visceral adipose tissue in some study populations. Researchers have reported decreases in trunk fat measured by computed tomography alongside changes in lipid markers. The mechanism is thought to involve growth hormone-mediated lipolysis, though the precise contribution of direct versus indirect pathways is not fully resolved. Studies have generally examined defined groups over finite periods, so long-term outcomes are less well characterized. Findings have not been uniform across all trials.

Background from the literature

The antigens are memorised by these cells so that subsequent exposure to the same type of antigens will stimulate a secondary response, in which a higher concentration of antibodies specific for the antigens are reproduced rapidly and efficiently in a short time for the elimination of the pathogen. Under specific circumstances, low doses of vaccines are given initially, followed by additional doses named booster doses. Boosters can effectively maintain the level of memory cells in the human body, hence extending a person's immunity.

Trump's trade policies were described as protectionist, neo-mercantilist, or autarkist, and increasing inflation became a more common critique of Trump's economic plans. In June 2024, 16 Nobel Prize in Economics laureates signed an open letter arguing that Trump's fiscal and trade policies coupled with efforts to limit the Federal Reserve's independence would reignite inflation in the United States. Moody's, as well as most economists surveyed by The Wall Street Journal in July 2024, predicted that inflation would be worse under Trump than Biden, a result due in part to tariffs, a crack down on illegal immigration, and larger deficits. Trump incorrectly insisted foreign exporters pay tariffs imposed by the U.S. government; American importers pay tariffs on goods upon arrival at U.S. ports, meaning tariffs are taxes that raise prices for imported products Americans buy. One non-partisan analysis estimated the proposed tariffs would cost $1,700 per year for the average household. The Committee for a Responsible Federal Budget found that Trump's plans would grow the national debt at roughly twice the rate of Harris' plan, while the Institute on Taxation and Economic Policy found Trump's plan would only benefit the top 5% of earners.

Operational control of combat units is divided between the service headquarters and domestic geographically based theatre commands. Theatre commands are multi-service ("joint") organizations that are broadly responsible for strategy, plans, tactics, and policy specific to their assigned area of responsibility. In wartime, they will likely have full control of subordinate units; in peacetime, units also report to their service headquarters. Force-building is the responsibility of the services and the CMC. The five theatre commands, in order of stated significance are:

As of 2013, consumption of magnesium alloys was less than one million tonnes per year, compared with 50 million tonnes of aluminium alloys. Their use has been historically limited by the tendency of Mg alloys to corrode, creep at high temperatures, and combust.

=== Transcriptional gene silencing === Many model organisms, such as plants (Arabidopsis thaliana), yeast (Saccharomyces cerevisiae), flies (Drosophila melanogaster), and worms (C. elegans), have been used to study small non-coding RNA-directed transcriptional gene silencing. In human cells, RNA-directed transcriptional gene silencing was observed in 2016 when exogenous siRNAs silenced a transgenic elongation factor 1α (EF1a) promoter driving a green fluorescent protein (GFP) reporter gene. The main mechanisms of transcriptional gene silencing (TGS) involving the RNAi machinery include DNA methylation, histone post-translational modifications, and subsequent chromatin remodeling around the target gene into a heterochromatic state.

Sources: en.wikipedia.org

Reference notes

Genetic defects in the collagen fibers of the basement membrane, including Alport syndrome and Knobloch syndrome Autoimmune diseases targeting basement membranes. Non-collagenous domain basement membrane collagen type IV is autoantigen (target antigen) of autoantibodies in the autoimmune disease Goodpasture's syndrome. A group of diseases stemming from improper function of the basement membrane zone are united under the name epidermolysis bullosa. In histopathology, thickened basement membranes are found in several inflammatory diseases, such as lichen sclerosus, systemic lupus erythematosus or dermatomyositis in the skin, or collagenous colitis in the colon.

Maximum levels for baby foods and chocolate/cocoa products were established under Commission Regulation (EU) No 488/2014. 1986 California Proposition 65 requires a warning label on chocolate products having more than 4.1 mg of cadmium per daily serving of a single product.

16th Airborne Division, under the command of Major-General Robert E. "Roy" Urquhart 42nd (Lancashire) Infantry Division 43rd (Wessex) Infantry Division 44th (Home Counties) Infantry Division 49th (West Riding & North Midland) Armoured Division (49th (West Riding and North Midland) Division/District in 1961) 50th (Northumbrian) Infantry Division (50th Northumbrian District by 1966) 51st/52nd (Lowland) Infantry Division 53rd (Welsh) Infantry Division 56th (London) Armoured Division 52nd (Lowland) Division was re-established as a tenth, 'mixed' division in March 1950. Three corps were planned to supervise the divisions. Two appear to have been actually formed, XXI (Northern) Corps, and XXIII (Southern) Corps. The planned 22nd Corps in Western Command was never formed although its sign, 'XXII in gold on blue with a red edge' was recorded in a Western Command letter to the War Office of 3rd July 1947 to be found in National Archives file WO32/18819. The Territorials also provided much of the Anti-aircraft warfare defence for the United Kingdom until 1956. In that year, Anti-Aircraft Command and 15 anti-aircraft regiments of the Royal Artillery were disbanded, with nine others passing into "suspended animation" as new English Electric Thunderbird Surface to Air Missile units replaced them. On 20 December 1955, the Secretary of State for War informed the House of Commons that the armoured divisions and the 'mixed' division were to be converted to infantry, and the 16th Airborne Division reduced to a parachute brigade group.

=== Role in melanoma metastasis === Heavily pigmented melanoma cells have a Young's modulus of about 4.93 kPa, compared to non-pigmented cells, with a value of 0.98 kPa. The elasticity of melanoma cells is crucial to metastasis and growth; non-pigmented tumors were larger than pigmented tumors, and spread far more easily. Pigmented and non-pigmented cells are both present in melanoma tumors, so that they can both be drug-resistant and metastatic.

Sources: en.wikipedia.org

Notes from published material

== Other == Lower levels of adiponectin are associated with ADHD in adults. Adiponectin levels were found to be increased in rheumatoid arthritis patients responding to DMARDs or TNF inhibitor therapy. A low adiponectin to leptin ratio has been found in patients with COVID-19 pneumonia compared to healthy controls. Exercise induced release of adiponectin increased hippocampal growth and led to antidepressive symptoms in mice. Several studies have found a positive correlation in caffeine consumption and increased adiponectin levels, although the mechanism for this is unknown and requires more research.

=== Heart and blood vessels === Bradycardia: Fentanyl decreases the heart rate by increasing vagal nerve tone in the brainstem, which increases the parasympathetic drive. Vasodilation: It also vasodilates arterial and venous blood vessels through a central mechanism, primarily by slowing down vasomotor centers in the brainstem. To a lesser extent, it does this by directly affecting blood vessels. This is much more profound in patients who have an already increased sympathetic drive, like patients who have high blood pressure or congestive heart failure. It does not affect the contractility of the heart when regular doses are administered.

==== Kinases ==== Protein kinases are the enzymes responsible for phosphorylation of serine and threonine residues. O-GlcNAc has been identified on over 100 (~20% of the human kinome) kinases, and this modification is often associated with alterations in kinase activity or kinase substrate scope. O-GlcNAc may have diverse functional consequences on kinases such as interfering with ATP binding, altering substrate recognition, or regulating other PTMs on kinases. Complex cross-talk relations can also exist where OGT and a kinase, e.g., AMPK, modify each other.

Sources: en.wikipedia.org

Frequently asked questions